Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilazodone Efficacy and Safety in MDD
NCT00683592Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Mar 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vilazodone in major depressive disorder (MDD), sponsored by Forest Laboratories. Started Mar 2008; status: completed.
02
Drugs
vilazodone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00683592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683592.